Arkema plans to start up its 50% expansion of Kynar fluoropolymer capacity at Changshu, China, next month. First commercial volumes will be supplied starting January 2021...
Pfizer has completed the spin-off of its Upjohn Business and combined it with Mylan to form Viatris, which began trading on Nov. 17. On closure of the deal, Pfizer...
Germany’s Wacker Chemie has signed a contract to manufacture the active substance for compatriot CureVac’s Covid-19 vaccine candidate CVnCoV. Under the terms, the biotech...
The Innovation Cup is an initiative for post-graduate students and young professionals in natural sciences, computer sciences, and business administration to attend a...
A New York state Supreme Court hearing Johnson & Johnson’s appeal of a 2019 baby powder judgment has agreed to reduce a $325 million jury award by two-thirds to $120...
Ineos Olefins and Polymers USA has agreed terms to buy Sasol’s 50% stake in their Gemini joint venture for $404 million, taking full ownership. The deal is scheduled to...
AstraZeneca’s viral vector vaccine candidate for Covid-19, AZD1222, moved back into the spotlight again this week after giving up headlines recently to the mRNA...
Dutch clinical-stage drug firm Lead Pharma has entered into a collaboration and license agreement with Swiss pharma giant Roche to develop oral small molecules for a...